Skip to main content

ADVERTISEMENT

health-economics

Real-World Analysis of Outpatient Rasburicase to Prevent and Manage Tumor Lysis Syndrome in Newly Diagnosed Adults With Leukemia or Lymphoma
Research Reports
03/16/2020
Scott C Howard, MD, MSc
Alex R Cockerham, PharmD, RPh, MSc
Edward Drea, PharmD
Yvonne Barnes, DNP, RN
Michael Ryan
William Irish, PhD
Lucio Gordan, MD
Abstract: Rasburicase, a recombinant urate oxidase used to manage hyperuricemia in patients at risk of tumor lysis syndrome, is increasingly being used in outpatient settings, but outcomes with this approach have not...
Abstract: Rasburicase, a recombinant urate oxidase used to manage hyperuricemia in patients at risk of tumor lysis syndrome, is increasingly being used in outpatient settings, but outcomes with this approach have not...
...
03/16/2020
Journal of Clinical Pathways